Monoclonal antibody therapeutics are highly effective in targeting specific proteins in the body and have gained immense popularity due to their advantages such as high specificity, low toxicity, and reduced side effects. The increasing prevalence of chronic diseases, rising geriatric population, and advancements in biotechnology are driving the demand for these therapeutics. Furthermore, the need to develop targeted therapies for diseases such as cancer, autoimmune ... Read more
The global Monoclonal Antibody Therapeutics Market Size is estimated to be valued at US$ 72.59 Bn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Monoclonal antibodies are therapeutic and diagnostic tools that bind to specific sites of substances such as infectious agents, cancer cells, or other toxins. They are used ... Read more
